Association Between Psoriasis and Non-Alcoholic Fatty Liver Disease: A Two-Sample Mendelian Randomization Study

Hong Li1 Department of Nursing, The Second Affiliated Hospital, Hunan University of Chinese Medicine, Changsha, People’s Republic of China;2 School of Nursing, Hunan University of Chinese Medicine, Changsha, People’s Republic of ChinaView further author information

Juan Su3 Department of Dermatology, Xiangya Hospital, Central South University, Changsha, People’s Republic of ChinaView further author information

Mingfang Zhu4 Department of Dermatology, The Second Affiliated Hospital, Hunan University of Chinese Medicine, Changsha, People’s Republic of ChinaView further author information

Yaqi Zhu1 Department of Nursing, The Second Affiliated Hospital, Hunan University of Chinese Medicine, Changsha, People’s Republic of China;2 School of Nursing, Hunan University of Chinese Medicine, Changsha, People’s Republic of ChinaView further author information

Shilin Zhu1 Department of Nursing, The Second Affiliated Hospital, Hunan University of Chinese Medicine, Changsha, People’s Republic of ChinaCorrespondence[email protected]

https://orcid.org/0000-0002-5994-5397 View further author information

References

Wenk KS, Arrington KC, Ehrlich A. Psoriasis and non-alcoholic fatty liver disease. J Eur Acad Dermatol Venereol. 2011;25(4):383–391. doi:10.1111/j.1468-3083.2010.03841.x
PubMed Web of Science ®Google Scholar
Gisondi P, Targher G, Zoppini G, Girolomoni G. Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol. 2009;51(4):758–764. doi:10.1016/j.jhep.2009.04.020
PubMed Web of Science ®Google Scholar
Ruan Z, Lu T, Chen Y, et al. Association between psoriasis and nonalcoholic fatty liver disease among outpatient US adults. JAMA Dermatol. 2022;158(7):745–753. doi:10.1001/jamadermatol.2022.1609
PubMed Web of Science ®Google Scholar
Naslund-Koch C, Bojesen SE, Gluud LL, Skov L, Vedel-Krogh S. Non-alcoholic fatty liver disease is not a causal risk factor for psoriasis: a Mendelian randomization study of 108,835 individuals. Front Immunol. 2022;13:1022460. doi:10.3389/fimmu.2022.1022460
PubMed Web of Science ®Google Scholar
Gau SY, Huang KH, Lee CH, Kuan YH, Tsai TH, Lee CY. Bidirectional association between psoriasis and nonalcoholic fatty liver disease: real-world evidence from two longitudinal cohort studies. Front Immunol. 2022;13:840106. doi:10.3389/fimmu.2022.840106
PubMed Web of Science ®Google Scholar
Gu X, Chen X, Shen M. Association of psoriasis with risk of COVID-19: a 2-sample Mendelian randomization study. J Am Acad Dermatol. 2022;87(3):715–717. doi:10.1016/j.jaad.2022.01.048
PubMed Web of Science ®Google Scholar
Camela E, Potestio L, Fabbrocini G, Pallotta S, Megna M. The holistic approach to psoriasis patients with comorbidities: the role of investigational drugs. Expert Opin Investig Drugs. 2023;32(6):537–552. doi:10.1080/13543784.2023.2219387
PubMed Web of Science ®Google Scholar

Association Between Psoriasis and Non-Alcoholic Fatty Liver Disease: A Two-Sample Mendelian Randomization Study

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Association Between Psoriasis and Non-Alcoholic Fatty Liver Disease: A Two-Sample Mendelian Randomization Study

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date